We have proposed that the accumulation of methylmalonyl-CoA, which occurs when a deficiency of B12 coenzyme exists, may lead to its incorporation into fatty acids in place of malonyl-CoA. This lead to the production of fatty acids, which are not usually produced and which may be physiologically undesirable. As a first step in the test of this hypothesis, we have examined the effect of methylmalonyl-CoA on fatty acid synthesis in vitro, in rat liver supernatant fractions. It was shown that methylmalonyl-CoA inhibits fatty acid synthesis and is incorporated into fatty acids.
No takes yet. Share an insight, caveat, or question.
Cardinale et al. (1970) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: